Abstract:Diabetic nephropathy (DN) is acknowledged as a serious chronic complication of diabetes mellitus. Nevertheless, its pathogenesis is complicated and unclear. Thus, in this study, the role of miR‐27a‐3p‐prohibitin/TMBIM6 signaling axis in the progression of DN was elucidated. Type 2 diabetic db/db mice and high glucose (HG)‐challenged HK‐2 cells were used as in vivo and in vitro models. Our results showed that miR‐27a‐3p was upregulated and prohibitin or transmembrane BAX inhibitor motif containing 6 (TMBIM6) was downregulated in the kidney tissues of db/db mice and HG‐treated HK‐2 cells. Silencing miR‐27a‐3p enhanced the expression of prohibitin and TMBIM6 in the kidney tissues and HK‐2 cells. Inhibition of miR‐27a‐3p improved functional injury, as evidenced by decreased blood glucose, urinary albumin, serum creatinine, and blood urea nitrogen levels. MiR‐27a‐3p silencing ameliorated renal fibrosis, reflected by reduced profibrogenic genes (e.g., transforming growth factor β1, fibronectin, collagen I and III, and α‐smooth muscle actin). Furthermore, inhibition of miR‐27a‐3p relieved mitochondrial dysfunction in the kidney of db/db mice, including upregulation of mitochondrial membrane potential, complex I and III activities, adenosine triphosphate, and mitochondrial cytochrome C , as well as suppressing reactive oxygen species production. In addition, miR‐27a‐3p silencing attenuated endoplasmic reticulum (ER) stress, reflected by reduced expression of p‐IRE1α, p‐eIF2α, XBP1s, and CHOP. Mechanically, we identified prohibitin and TMBIM6 as direct targets of miR‐27a‐3p. Inhibition of miR‐27a‐3p protected HG‐treated HK‐2 cells from apoptosis, extracellular matrix accumulation, mitochondrial dysfunction, and ER stress by regulating prohibitin or TMBIM6. Taken together, we reveal that miR‐27a‐3p‐prohibitin/TMBIM6 signaling axis regulates the progression of DN, which can be a potential therapeutic target.

Mechanism of Mir-365 in Regulating BDNF-TrkB Signal Axis of HFD/STZ Induced Diabetic Nephropathy Fibrosis and Renal Function

Upregulation of Mirna-1228-3p Alleviates TGF-β-induced Fibrosis in Renal Tubular Epithelial Cells.

Mir-130b Increases Fibrosis Of Hmc Cells By Regulating The Tgf-Beta 1 Pathway In Diabetic Nephropathy

Mir-98-5p Alleviated Epithelial-to-Mesenchymal Transition and Renal Fibrosis Via Targeting Hmga2 in Diabetic Nephropathy

Downregulation of Mir-30C Promotes Renal Fibrosis by Target CTGF in Diabetic Nephropathy.

Differential Expression and Therapeutic Efficacy of Microrna-346 in Diabetic Nephropathy Mice

MiRNA-133a-3p Attenuates Renal Tubular Epithelial Cell Injury via Targeting MALM1 and Suppressing the Notch Signaling Pathway in Diabetic Nephropathy

MicroRNA-29b Inhibits Diabetic Nephropathy in Db/db Mice.

P0987MIR-181A IMPROVED RENAL INFLAMMATION VIA TARGETING TNF-Α IN DIABETIC NEPHROPATHY

miR-374a Regulates Inflammatory Response in Diabetic Nephropathy by Targeting MCP-1 Expression.

Inhibition Of Mirna-135a-5p Ameliorates Tgf-Beta 1-Induced Human Renal Fibrosis By Targeting Sirt1 In Diabetic Nephropathy

Hsa-Mir-199b-3p Prevents the Epithelial-Mesenchymal Transition and Dysfunction of the Renal Tubule by Regulating E-cadherin Through Targeting KDM6A in Diabetic Nephropathy

Low Expression of Mir-203 Promoted Diabetic Nephropathy Via Increasing TLR4.

Involvement of miR‐27a‐3p in diabetic nephropathy via affecting renal fibrosis, mitochondrial dysfunction, and endoplasmic reticulum stress

miR-136 improves renal fibrosis in diabetic rats by targeting down-regulation of tyrosine kinase SYK and inhibition of TGF-β1/Smad3 signaling pathway.

MiR‐874 Alleviates Renal Injury and Inflammatory Response in Diabetic Nephropathy Through Targeting Toll‐like Receptor‐4

Involvement of Inflammation-Related Mir-155 and Mir-146A in Diabetic Nephropathy: Implications for Glomerular Endothelial Injury

Mir-23A-3p Regulates the Inflammatory Response and Fibrosis in Diabetic Kidney Disease by Targeting Early Growth Response 1

Mir-21 Overexpression Enhances TGF-β1-induced Epithelial-to-mesenchymal Transition by Target Smad7 and Aggravates Renal Damage in Diabetic Nephropathy.

MiR-133 inhibits kidney injury in rats with diabetic nephropathy via MAPK/ERK pathway

Tongxinluo ameliorates renal structure and function by regulating miR-21-induced epithelial-to-mesenchymal transition in diabetic nephropathy.